Comprising both reactive and non-reactive controls for Anti SARS-CoV-2, the Acusera SARS-CoV-2 Antibody Control from Randox Laboratories, Kearney, WV, will support assay validation and routine performance monitoring of serological assays for covid-19. Conveniently supplied in a liquid ready-to-use format with a 30-day open vial stability at 2°C to 8°C, waste is kept to a minimum. As a true third-party control, independent performance assessment is guaranteed.

Whereas PCR tests for SARS-CoV-2 the virus causing covid-19 are designed to detect active infections, antibody testing can accurately determine previous infection to the virus and are especially useful in identifying individuals who may have been infected but did not display symptoms. As such, serology tests are critical to ongoing surveillance studies, epidemiological studies, and vaccine trials. Serology testing is also currently being used as part of confirmatory testing strategies.

Quality control plays a critical role in these studies, allowing laboratories and clinicians to release patient results with confidence.

For more information, visit Randox

Featured image: Acusera SARS-CoV-2 Antibody Control (Courtesy: Randox Laboratories)